Therapeutic vaccine for melanoma to be tested, with and without IL-2

被引：0
|
作者：
不详
机构：
来源：
BIOTECHNOLOGY LAW REPORT | 1996年 / 15卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
下载
收藏
页码：594 / 594
页数：1
相关论文
共 50 条
  • [1] ALLOGENEIC HUMAN LIPOSOMAL MELANOMA VACCINE WITH OR WITHOUT IL-2 IN METASTATIC MELANOMA PATIENTS - CLINICAL AND IMMUNOBIOLOGICAL EFFECTS
    ADLER, A
    SCHACHTER, J
    BARENHOLZ, Y
    BAR, LK
    KLEIN, T
    KORYTNAYA, R
    SULKES, A
    MICHOWIZ, R
    COHEN, Y
    KEDAR, I
    CANCER BIOTHERAPY, 1995, 10 (04): : 293 - 306
  • [2] Potentiation of melanoma vaccine activity by IL-2 liposomes.
    Bystryn, JC
    Oratz, R
    Shapiro, R
    Johnston, D
    Harris, M
    Roses, D
    ZeleniuchJacquotte, A
    Chen, DL
    Lax, A
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 235 - 235
  • [3] IL-2 boosts cancer vaccine
    Alan Dove
    Nature Biotechnology, 1999, 17 (4) : 317 - 317
  • [4] Randomized Phase II Study of IL-2 With or Without an Allogeneic Large Multivalent Immunogen Vaccine for the Treatment of Stage IV Melanoma
    Jha, Gautam
    Miller, Jeffrey S.
    Curtsinger, Julie M.
    Zhang, Yan
    Mescher, Mathew F.
    Dudek, Arkadiusz Z.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (03): : 261 - 265
  • [5] Transfection of IL-2 augments CTL response to human melanoma cells in vitro: Immunological characterization of a melanoma vaccine
    vanElsas, A
    Aarnoudse, C
    vanderMinne, CE
    vanderSpek, CW
    Brouwenstijn, N
    Osanto, S
    Schrier, PI
    JOURNAL OF IMMUNOTHERAPY, 1997, 20 (05) : 343 - 353
  • [6] Therapeutic efficiency of IL-2 gene transduced tumor vaccine for head and neck carcinoma
    Mizuno, H
    Yanoma, S
    Nishimura, G
    Hattori, S
    Ito, T
    Okudera, K
    Tsukuda, M
    CANCER LETTERS, 2000, 152 (02) : 175 - 185
  • [7] IL-2 in the therapy of melanoma and other malignancies
    Margolin, Kim
    MEDICAL ONCOLOGY, 2009, 26 : 23 - 31
  • [8] IL-2 in the therapy of melanoma and other malignancies
    Kim Margolin
    Medical Oncology, 2009, 26 : 23 - 31
  • [9] Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma
    Redman, Bruce G.
    Chang, Alfred E.
    Whitfield, Joel
    Esper, Peg
    Jiang, Guihua
    Braun, Thomas
    Roessler, Blake
    Mule, James J.
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (06) : 591 - 598
  • [10] Dacarbazine, cisplatin and IFN-α with or without IL-2 in advanced melanoma (EORTC trial 18951).
    Keilholz, U
    Punt, CJA
    Gore, M
    Kruit, W
    Patel, P
    Lienard, D
    van Oosterom, AT
    Proebstle, T
    Eggermont, AMM
    ANNALS OF ONCOLOGY, 2000, 11 : 4 - 4
12345